AK MEDICAL (01789) disclosed the latest Next Day Disclosure Return dated 13 February 2026. The opening balance of issued shares was 1.12 billion as of 6 February 2026, and the closing balance remains unchanged at 1.12 billion, as no new shares were issued or cancelled during this period.

According to the document, 0.64 million shares were repurchased for cancellation on 6 February 2026 at HKD 5.92 each, accounting for approximately 0.0569%. On 13 February 2026, 1.09 million shares were further repurchased for cancellation at HKD 6.21 each, representing 0.0968%. As these shares have not yet been cancelled, they remain part of the total 1.12 billion shares.

Subsequent details indicate that the repurchase on 13 February 2026 involved a highest price of HKD 6.24, a lowest price of HKD 6.15, and a total consideration of HKD 6.76 million. The repurchase mandate was granted on 18 June 2025, authorizing up to 112.27 million shares for potential repurchase, representing approximately 1.54% of the total at that time. A 30-day moratorium period on new share issues or the sale or transfer of treasury shares is in effect through 15 March 2026.